Modernizing Drug Development in the Face of the COVID-19 Pandemic

Video

Drug development paradigms need to change in order to quickly bring new therapeutics to patients affected by pandemics like COVID-19. 

Related Videos
Jason Tate, FSP Talent Strategy Lead, PPD, part of Thermo Fisher Scientific
Corevitas Clinical Trials